Carecloud Inc Stock Price, News & Analysis

CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.

Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.

CareCloud (Nasdaq: CCLD) will release third quarter 2025 financial results for the period ended September 30, 2025 before the market opens on Thursday, November 6, 2025. A conference call for investors is scheduled for 8:30 a.m. Eastern Time the same day. A live webcast and presentation slides will be available at ir.carecloud.com/events; an audio-only option is available via dial-in numbers. A replay and slides will be posted roughly three hours after the call at the same link.

CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B cumulative perpetual preferred shares for October, November and December 2025.

Key facts: monthly dividend per share $0.18229 for each series; Series A holders receive an additional payment tied to a prior 11% rate that equals $0.04688 (Oct), $0.01719 (Nov) and $0.00 (Dec); ex-dividend and record dates are the last day of each month (Oct 31, Nov 30, Dec 31, 2025); payment dates are Nov 17, 2025, Dec 15, 2025 and Jan 15, 2026.

Dividends are cumulative, calculated at 8.75% per annum on the $25 liquidation preference (equivalent to $2.1875 per annum per share). Previously converted Series A holders who converted on March 6, 2025 are not eligible for these payments.

CareCloud (NASDAQ: CCLD) has announced a definitive agreement to acquire HFMA's MAP App, a leading hospital benchmarking tool, with the deal set to close on October 1, 2025. The acquisition includes a long-term joint marketing agreement with the Healthcare Financial Management Association (HFMA).

MAP App, developed by HFMA and used by top hospitals nationwide, specializes in benchmarking and measuring revenue cycle management performance. CareCloud plans to enhance the tool's capabilities with AI-driven insights through its AI Center of Excellence, building on synergies from its recent Medsphere hospital IT business acquisition.

The partnership aims to expand MAP App's reach and capabilities while leveraging HFMA's network of 140,000 members. The acquisition is not expected to have a material financial impact on CareCloud in 2025.

CareCloud (NASDAQ: CCLD) has unveiled Marketware, a physician relationship management and analytics platform acquired through its recent Medsphere acquisition. The platform helps hospitals strengthen physician alignment, optimize referral networks, and drive measurable growth.

Marketware's key features include tracking referral patterns, reducing network leakage, and providing actionable intelligence through interactive dashboards. The platform is being integrated with CareCloud's AI Center of Excellence, revenue cycle management tools, and inpatient EHR solutions.

A live demonstration of Marketware is scheduled for October 8, 2025, at 1:00 PM ET, where hospitals can explore the platform's capabilities and learn about CareCloud's growth vision.

CareCloud (NASDAQ: CCLD) has secured a new $10 million credit facility with Provident Bank, with approximately $8.3 million drawn at closing to support the recent Medsphere Systems Corporation acquisition. The facility, closed on September 3, 2025, replaces a previous Wells Fargo promissory note with more favorable terms.

The credit facility features an interest rate of SOFR plus 3% (currently under 7.5%) and a two-year term. This financing supports the $16.5 million Medsphere acquisition, of which $8.25 million was paid at closing from internal cash flow. CareCloud plans to fully pay down the Medsphere-related obligation by mid-2026 through internally generated cash flow.

CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.

The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.

CareCloud (Nasdaq: CCLD) has completed the acquisition of Medsphere Systems Corporation, marking a significant expansion into the hospital IT market. The deal brings together Medsphere's extensive client base of over 600 healthcare facilities across 50 states with CareCloud's AI and R&D capabilities.

The acquisition includes Medsphere's comprehensive hospital IT ecosystem featuring CareVue (integrated inpatient EHR), RCM Cloud (revenue cycle management), Wellsoft (Emergency Department Information System), HealthLine (supply chain management), ChartLogic (ambulatory EHR), and managed IT services. This strategic move positions CareCloud to provide affordable, AI-enhanced healthcare technology solutions specifically targeted at small and mid-sized hospitals.

CareCloud (Nasdaq: CCLD) reported strong Q2 2025 financial results, marking its first quarter of positive GAAP EPS since going public in 2014. The company achieved GAAP net income of $2.9 million, a 73% increase from Q2 2024, and revenue of $27.4 million.

Key highlights include the launch of their AI Center of Excellence, scaling to 500 team members by year-end, and the completion of two acquisitions in 2025. The company reaffirmed its 2025 guidance, projecting revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and GAAP EPS of $0.10-0.13.

Year-to-date performance showed strong growth with GAAP net income up 238% to $4.9 million and free cash flow increasing 85% to $9.0 million compared to the same period last year.